Trade
Trading Type
Spot
Trade crypto freely
Alpha
Points
Get promising tokens in streamlined on-chain trading
Pre-Market
Trade new tokens before they are officially listed
Margin
Magnify your profit with leverage
Convert & Block Trading
0 Fees
Trade any size with no fees and no slippage
Leveraged Tokens
Get exposure to leveraged positions simply
Futures
Futures
Points
Hundreds of contracts settled in USDT or BTC
Options
HOT
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Participate in events to win generous rewards
Demo Trading
Use virtual funds to experience risk-free trading
Earn
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
New
Trade on-chain assets and enjoy airdrop rewards!
Futures Points
New
Earn futures points and claim airdrop rewards
Investment
Simple Earn
Earn interests with idle tokens
Auto-Invest
Auto-invest on a regular basis
Dual Investment
Buy low and sell high to take profits from price fluctuations
Soft Staking
Earn rewards with flexible staking
Crypto Loan
0 Fees
Pledge one crypto to borrow another
Lending Center
One-Stop Lending Hub
VIP Wealth Hub
New
Customized wealth management empowers your assets growth
Private Wealth Management
Customized asset management to grow your digital assets
Quant Fund
Top asset management team helps you profit without hassle
Staking
Stake cryptos to earn in PoS products
BTC Staking
HOT
Stake BTC and earn 10% APR
GUSD Minting
New
Use USDT/USDC to mint GUSD for treasury-level yields
More
- Trending TopicsView More
21.94K Popularity
67.01K Popularity
36.36K Popularity
8.23K Popularity
22.13K Popularity
- Hot Gate FunView More
- MC:$4.13KHolders:10.00%
- MC:$4.16KHolders:20.02%
- MC:$4.05KHolders:10.00%
- MC:$4.01KHolders:10.00%
- MC:$3.97KHolders:10.00%
- Pin
- 🚀 #GateNewbieVillageEpisode5 ✖️ @Surrealist5N1K
💬 Stay clear-headed in a bull market, calm in a bear market.
Share your trading journey | Discuss strategies | Grow with the Gate Family
⏰ Event Time: Nov 5 10:00 – Nov 12 26:00 UTC
How to Join:
1️⃣ Follow Gate_Square + @Surrealist5N1K
2️⃣ Post on Gate Square with the hashtag #GateNewbieVillageEpisode5
3️⃣ Share your trading experiences, insights, or growth stories
— The more genuine and insightful your post, the higher your chance to win!
🎁 Rewards
3 lucky participants → Gate X RedBull Cap + $20 Position Voucher
If delivery is unavailable, th - 💥 Gate Square Event: #PostToWinPIGGY 💥
Post original content on Gate Square related to PIGGY or Launchpool for a chance to share 200 PIGGY rewards!
📅 Event Period: Oct 30, 2025, 10:00 – Nov 6, 2025, 16:00 (UTC)
📌 Related Campaign:
Launchpool 👉 https://www.gate.com/announcements/article/47886
📌 How to Participate:
1️⃣ Post original content related to PIGGY or the Launchpool campaign.
2️⃣ Content must be at least 80 words.
3️⃣ Add the hashtag #PostToWinPIGGY
4️⃣ Include a screenshot showing your participation in the Launchpool.
🏆 Rewards (Total: 200 PIGGY)
🥇 1st Prize (1 winners): 40 PI - 🚀 Gate Square Creator Certification Incentive Program Is Live!
Join Gate Square and share over $10,000 in monthly creator rewards!
Whether you’re an active Gate Square creator or an established voice on another platform, consistent quality content can earn you token rewards, exclusive Gate merch, and massive traffic exposure!
✅ Eligibility：
You can apply if you meet any of the following:
1️⃣ Verified creator on another platform
2️⃣ At least 1,000 followers on a single platform (no combined total)
3️⃣ Gate Square certified creator meeting follower and engagement criteria
Click to apply now 👉
Lianhuan Pharmaceutical: The LH-1801 project faces significant uncertainties at multiple critical stages from successful clinical trials to final market launch and profitability.
Jin10 data reported on July 8th that Lianhuan Pharmaceutical issued an announcement regarding abnormal fluctuations in stock trading. The LH-1801 project clinical trial adopts a non-inferiority design, and there is significant uncertainty regarding whether the target can ultimately be achieved. The LH-1801 project faces significant uncertainties in multiple key segments from successful clinical trials to final market launch and profitability. The LH-1801 project is currently still in the R&D stage and is expected to not have a significant impact on the company’s operating income and performance for a considerable period of time.